PharmaCare 2018

PharmaCare 2018

[Italiano]: Il farmaco, nella sua accezione più ampia e generale, può essere ritenuto un bene sociale, la cui valenza simbolica e curativa varia in relazione alla dimensione ambientale e culturale nel quale si inserisce. In tal senso, le prescrizioni farmaceutiche rappresentano un indicatore privile...

Full description

Bibliographic Details
Format:	eBook
Published:	FedOA - Federico II University Press 2020
Online Access:	Open Access: DOAB, download the publication Open Access: DOAB: description of the publication

Similar Items

Pharmacare 2019
Published: (2021)

National Pharmacare in Canada: 2019 or Bust?
by: Owen Adams, et al.
Published: (2017-03-01)

Planning a pharmacare program for the Northwest Territories
by: Pontus, Michael Stephen
Published: (2010)

A Time for Change: The Argument for National Pharmacare
by: Rahul Sharma
Published: (2021-08-01)

Universal Pharmacare in Canada: A Prescription for Equity in Healthcare
by: Mohammad Hajizadeh, et al.
Published: (2020-03-01)

It Won’t Be Easy: How to Make Universal Pharmacare Work in Canada
by: Steven Lewis
Published: (2020-01-01)

Putting National Pharmacare on the Federal Agenda: Creation of an Advisory Council
by: Michel Grignon, et al.
Published: (2019-08-01)

Pharma-News
Published: (2012-01-01)

Glocal Pharma
by: Johnson, Ericka
Published: (2016)

Glocal Pharma
Published: (2016)

An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
by: Coombes, Megan Eileen
Published: (2009)

An intra- & inter-provincial analysis of the Fair Pharmacare policy in British Columbia
by: Coombes, Megan Eileen
Published: (2009)

Pharma-News-Takeda
Published: (2014-01-01)

The impact of area-based cultural characteristics on participation with the Fair Pharmacare program in BC
by: Leong, Vivian Wai-Sum
Published: (2008)

The impact of area-based cultural characteristics on participation with the Fair Pharmacare program in BC
by: Leong, Vivian Wai-Sum
Published: (2008)

The impact of area-based cultural characteristics on participation with the Fair Pharmacare program in BC
by: Leong, Vivian Wai-Sum
Published: (2008)

Valuation of target companies in mergers and acquisitions: the case of Aspen Pharmacare and Adcock Ingram
by: Madisa, Nompumelelo
Published: (2016)

Study of the skincalm filling process at Aspen Pharmacare applying some six sigma principles
by: Marx, Johannes
Published: (2005)

An open source pharma roadmap.
by: Manica Balasegaram, et al.
Published: (2017-04-01)

Big Pharma, Big Business
by: Sorin-George Toma, et al.
Published: (2021-01-01)

Words for pharma: a quantitative and qualitative analysis on vision, mission and values of multinational pharma companies.
by: Giulio Zuanetti, et al.
Published: (2020-04-01)

Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare
by: Jaden Brandt, et al.
Published: (2018-11-01)

Equity in the use and financing of medicines in British Columbia before and after the move to income-based pharmacare
by: Hanley, Gillian Elizabeth
Published: (2011)

Equity in the use and financing of medicines in British Columbia before and after the move to income-based pharmacare
by: Hanley, Gillian Elizabeth
Published: (2011)

Equity in the use and financing of medicines in British Columbia before and after the move to income-based pharmacare
by: Hanley, Gillian Elizabeth
Published: (2011)

Formation and development perspectives of eco-pharma
by: A. A. Kotvitska, et al.
Published: (2019-02-01)

Collaborative Innovation: The Future of BioPharma
by: Cristián Hernández-Cuevas
Published: (2007-09-01)

Antioxidant Phytochemicals at the Pharma-Nutrition Interface
by: Elena Azzini, et al.
Published: (2017-01-01)

On the Valuation of ‘Big Pharma’s’ Research Pipelines
by: Löfqvist, Martin
Published: (2009)

Big pharma gives millions to Congress
by: Robbins RA
Published: (2018-10-01)

Purdue Pharma Deceptive Research Misconduct
by: Jason Sanchez Alonso
Published: (2021-02-01)

The growth strategies of a global pharmaceutical company: a case study of Aspen Pharmacare Holdings Limited
by: Victoria Margaret Hodgon, et al.
Published: (2017-05-01)

Advances in Pharma Business Management and Research Volume 1
Published: (2020)

EXAMINATION OF IMPACT OF PHARMA R&D ON PROFITABILITY
by: Gergo Tomori
Published: (2014-07-01)

A Counterfeit Solution for Pharma Supply Chain
by: Soundarya K., et al.
Published: (2018-04-01)

Recent trends in specialty pharma business model
by: Mannching Sherry Ku
Published: (2015-12-01)

Pricing of Pharmaceutical Products in SME Pharma Units
by: Dr. J. K. Panda, et al.
Published: (2012-12-01)

Open source pharma and its developmental potential
by: Valeria Arza, et al.
Published: (2018-06-01)

Immunity and Impunity: Corruption in the State-Pharma Nexus
by: Paddy Rawlinson
Published: (2017-11-01)

Advances in Pharma Business Management and Research : Volume 1
Published: (2020)